Inviragen Researching Vaccines To Protect Against Pandemic And Seasonal Influenza Viruses
Based on its ongoing avian influenza vaccine research, Inviragen is designing vaccines to protect against multiple influenza strains, including seasonal influenza and the recently emerged H1N1 influenza strain. The H1N1 influenza virus has caused nearly 30,000 cases worldwide in 74 countries leading to 144 deaths. In contrast, while no H5N1 avian influenza strain capable of human-to-human transmission has yet emerged, the high mortality of the virus represents a threat for future epidemics.
Related Posts
Tags: against, efficacy, influenza, inviragen, pandemic, protect, researching, seasonal, vaccines, viruses
This entry was posted on Monday, June 15th, 2009 at 4:06 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



